OncoNano Medicine
Raphael E. Pollock, MD, PhD joined the faculty of the University of Texas MD Anderson Cancer Center in 1984 upon completion of fellowship training at that institution. In 1993, Dr. Pollock began service as Chairman of the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center, a position that he held until 2010. In 1996, service as Head of the Division of Surgery at the University of Texas MD Anderson Cancer Center was begun, a position entailing supervisory relationships with all seven surgical specialty departments at that institution. In 2013, Dr. Pollock was recruited to The Ohio State University as Professor and Director of the Division of Surgical Oncology and Chief of Surgical Services at the James Comprehensive Cancer Center, followed by appointment as Surgeon in Chief, The Ohio State University Health System, in 2015. In 2017, Dr. Pollock was appointed to his current position as Professor and Director, The Ohio State University Comprehensive Cancer Center.
This person is not in the org chart
This person is not in any offices
OncoNano Medicine
OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple, and effective identifier of diseased tissue providing a foundation for the development of a broad range of highly targeted therapeutics and imaging agents.